Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices

被引:71
|
作者
Skene, DJ [1 ]
Papagiannidou, E [1 ]
Hashemi, E [1 ]
Snelling, J [1 ]
Lewis, DFV [1 ]
Fernandez, M [1 ]
Ioannides, C [1 ]
机构
[1] Univ Surrey, Sch Biol Sci, Guildford GU2 5XH, Surrey, England
关键词
CYP1A2; cytochrome P450; enzyme induction; liver slices; melatonin; 6-sulphatoxymelatonin;
D O I
10.1034/j.1600-079X.2001.310408.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of the present studies was to define the enzyme systems catalysing the 6-hydroxylation of melatonin, by monitoring the levels of 6-sulphatoxymelatonin in rat hepatic postmitochondrial preparations and in precision-cut liver slices. Melatonin 6-hydroxylase activity was localized in microsomes and was supported by NADPH, but not NADH. Treatment of rats with beta -naphthoflavone more than tripled 6-sulphatoxymelatonin formation from melatonin, but gave rise only to a moderate increase (25%) in the sulphate conjugation of 6-hydroxymelatonin. Treatment of rats with phenobarbitone, acetone, dexamethasone and clofibrate did not increase 6-sulphatoxymelatonin generation when either melatonin or 6-hydroxymelatonin served as substrates. Of a number of cytochrome P450 inhibitors investigated, only furafylline inhibited markedly the conversion of melatonin to 6-sulphatoxymelatonin without any concomitant effect on the sulphoconjugation of 6-hydroxymelatonin. When liver slices were incubated with melatonin, treatment of rats with beta -naphthoflavone, and to a lesser extent phenobarbitone. elevated the levels of 6-sulphatoxymelatonin in the culture medium. No such increase was seen when slices from beta -naphthoflavone-treated rats were incubated with 6-hydroxymelatonin, whereas a modest increase was seen with slices from phenobarbitone-treated rats. Treatment of rats with acetone, dexamethasone or clofibrate railed to modulate the levels of 6-sulphatoxymelatonin generated from either melatonin or 6-hydroxymetatonin. Molecular modelling analysis revealed that melatonin had a high area/depth(2) ratio, displayed characteristics of CYP1A2 substrates and could be readily accommodated into the human CYP1A2 active site in a position favouring 6-hydroxylation. Collectively, all the above data provide strong experimental evidence that CYP1A2 is an important catalyst of the 6-hydroxylation of melatonin.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 50 条
  • [41] 4-aminobiphenyl-induced liver and urinary bladder DNA adduct formation in Cyp1a2(-/-) and Cyp1a2(+/+) mice
    Tsuneoka, Y
    Dalton, TP
    Miller, ML
    Clay, CD
    Shertzer, HG
    Talaska, G
    Medvedovic, M
    Nebert, DW
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (16) : 1227 - 1237
  • [42] 3,3′-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices
    Lake, BG
    Tredger, JM
    Renwick, AB
    Barton, PT
    Price, RJ
    XENOBIOTICA, 1998, 28 (08) : 803 - 811
  • [43] Enantioselective metabolism of phenylpyrazole insecticides by rat liver microsomal CYP3A1, CYP2E1 and CYP2D2
    Zhang, Zhaoxian
    Wang, Zhiqiang
    Li, Qing X.
    Hua, Rimao
    Wu, Xiangwei
    PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY, 2021, 176
  • [44] Concentration dependent stereoselectivity of propafenone N-depropylation metabolism with human hepatic recombinant CYP1A2
    Zhou, Q
    Yao, TW
    Yu, YN
    Zeng, S
    PHARMAZIE, 2003, 58 (09): : 651 - 653
  • [45] Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-Null mouse
    Zaher, H
    Yang, TJ
    Gelboin, HV
    FernandezSalguero, P
    Gonzalez, FJ
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (02) : 235 - 238
  • [46] Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin
    Chang, Thomas K. H.
    Chen, Jie
    Yang, Guixiang
    Yeung, Eugene Y. H.
    JOURNAL OF PINEAL RESEARCH, 2010, 48 (01) : 55 - 64
  • [47] Assays for CYP1A2 by testing in vivo metabolism of caffeine in humans
    Tang, BK
    Kalow, W
    CYTOCHROME P450, PT B, 1996, 272 : 124 - 131
  • [48] IN VITRO AND IN VIVO INHIBITION OF CYP1A2 METABOLISM BY NATURAL FURANOCOUMARINS
    Li, H.
    Zhuang, X.
    Kong, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 164 - 164
  • [49] Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma
    Obase, Y
    Shimoda, T
    Kawano, T
    Saeki, S
    Tomari, S
    Mitsuta-Izaki, K
    Matsuse, H
    Kinoshita, M
    Kohno, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (05) : 468 - 474
  • [50] CYP1A2 polymorphisms and clozapine metabolism in Chinese psychotic patients
    Chen, J. Y.
    Chen, T. T.
    Liou, Y. J.
    Yen, C. F.
    Chang, W. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S481 - S482